期刊文献+

90例老年女性卵巢肿瘤的临床分析 被引量:3

Clinical analysis of 90 cases of aged women′s ovarian tumor
下载PDF
导出
摘要 目的:探讨老年女性卵巢肿瘤的临床和病理特征,分析其诊断与治疗方法。方法:以经手术确诊的90例≥65岁的老年女性卵巢肿瘤患者为研究对象,对其临床资料及病理结果进行回顾性分析。结果:90例患者中38例有腹胀,腹痛,31例自我触及腹部包快,8例有不规则阴道流血,8例有下腹部不适等非特异性症状,5例无症状;恶性肿瘤66例,占73.3%,交界性肿瘤10例,占11.1%,良性肿瘤14例,占15.6%;恶性和交界性肿瘤CA-125、AFP、CEA明显高于良性肿瘤(P<0.05),恶性肿瘤超声表现多为囊实不均混合回声,形态欠规则,边界欠清晰,大多伴有腹水。结论:老年女性卵巢肿瘤恶性率比较高,应定期进行妇科检查,并结合肿瘤标记物和妇科彩超等影像学特征,作到早期诊断,早期治疗,提高生活质量及延长生存率。 Objective To analyze the clinical and pathologic characteristics of aged women′s ovarian tumor,and explore its diagnosis and treatment.Method The clinical data and pathologic results were analyzed retrospectively in 90 patients with ovarian tumor over 65 years old.Results Among the 90 cases,38 had abdominal distention or abdominal pain,31 had self-conscious abdominal mass,8 had colporrhagia,8 had symptoms such as hypogastrium discomfort,and 5 had no symptoms.Among them,66 cases(73.3%) were malignant ovarian tumors,10(11.1%)were borderline tumors and 14(15.6%)were benign tumors.The positive rates of serum CA-125,AFP and CEA were significantly higher in malignant and borderline cases(P0.05) than in benign ones.Ultrasound examination showed that the malignant ovarian tumors were most cyst-parenchymatous image,the forms were less under rules,and the boundary was less clear,and most of them always showed ascites.Conclusion Aged women′ ovarian tumor has higher incidence of malignancy.These women should be examined regularly.Tumor markers and image technique are all important in the early diagnosis.Once confirmed,early treatment are needed,in order to improve the quality of life and extend survival.
出处 《吉林医学》 CAS 2012年第31期6735-6737,共3页 Jilin Medical Journal
关键词 卵巢肿瘤 老年女性 临床分析 Ovarian tumor Aged women Clinical analysis
  • 相关文献

参考文献9

  • 1ZHOU Bo,SUN Qing-min,CONG Ri-hong,et al.Hor-mone replacement therapy and ovarian cancer risk:a meta-analy-sis[J].Gynecologic Oncology.2008,110(3):455.
  • 2Lacey JV Jr,Brinton LA,Leitzmann MF,et al.Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort[J].Journal of the National Cancer Institute[J].2006,98(19):1397.
  • 3Anderson GL,Judd HL,Kaunitz AM,et al.Effects of estro-gen plus progestin on gynecologic cancers and associated diagnos-tic procedures:the Women's Health Initiative randomized trial[J].JAMA,2003,290(13):1739.
  • 4Garg PP,Kerlikowske K,Subak L,et al.Hormone replace-ment therapy and the risk of epithelial ovarian carcinoma:a meta-analysis[J].Obstet Gynecol,1998,92(3):472.
  • 5Mills PK,Riordan DG,Cress RD,et al.Hormone replace-ment therapy and invasive and borderline epithelial ovarian cancer risk[J].Cancer Detect Prev,2005,29(2):124.
  • 6Mitic N,Milutinovic B,Jankovic M.Assessment of sialic acid diversity in cancer-and non-cancer related CA125antigen using sialic acid-binding Ig-like lectins(Siglecs)[J].Dis Markers,2012,32(3):187.
  • 7Abbasi A,Bhutto AR,Butt N,et al.Corelation of serum al-pha fetoprotein and tumor size in hepatocellular carcinoma[J].J Pak Med Assoc,2012,62(1):33.
  • 8Fijneman RJ,de Wit M,Pourghiasian M,et al.Proximal flu-id proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer[J].Clin Cancer Res,2012,18(9):2613.
  • 9Zur B,Holdenrieder S,Walgenbach-Brünagel G,et al.Method comparison for determination of the tumor markers AFP,CEA,PSA and free PSA between Immulite2000XPI and Dimen-sion Vista1500[J].Clin Lab,2012,58(1-2):97.

同被引文献31

  • 1华克勤,金福明,徐焕,朱芝玲,林金芳,丰有吉.腹腔镜手术治疗早期低危型卵巢恶性肿瘤的价值[J].中华医学杂志,2005,85(3):169-172. 被引量:18
  • 2孙静,金露青,林敏,葛蓓蕾,顾磊,史小菲,童晓文.妇科腹腔镜手术并发症分析及预防[J].中国微创外科杂志,2007,7(5):463-465. 被引量:29
  • 3Braem MG, Onland-Moret NC, Schouten LJ,et al.Multiple Miscarriages Are Associated with the Risk of Ovarian Cancer: Results from the European Prospective Investigation into Cancer and Nutrition.PLoS One, 2012,7:e37141.
  • 4Prizment AE, Folsom AR, Anderson KE. Nons teroidal anti- inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study. Cancer Epidemiol Biomark- ers Prev,2010, 19:435-442.
  • 5Le DC, Kubo T, Fujnio Y, et al.Reproductive factors in relation to ovarian cancer: a case-control study in Northern Vietnam. Contraception, 2012, 86:494-499.
  • 6Pajenga E, Rexha T, 2eliku S, et al. Hormonal risk factors for ovarian cancer in the Albanian case-control study.Bosn J Basic Med Sci, 2013, 13:89-93.
  • 7Braem MG, Onland-Motet NC, van den Brandt PA, et al .Reproductive and hormonal factors in association with ovar- ian cancer in the Netherlands eohort study.Am J Epidemiol, 2010, 172: 1181-1189.
  • 8Gong TT,Wu QJ,Vogtmann E,et al. Age at menarche and risk of ovarian cancer:A meta-analysis of epidemiological studies. Int J Cancer, 2013, 132: 2894-2900.
  • 9Emmanuel C, Gava N, Kennedy C, et al .Comparison of expres- sion profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogen- esis. PLoS One, 2011,6:e17617.
  • 10全国妇产科内镜应用学术研讨会纪要[J].中华妇产科杂志,1997,32(5):263-266. 被引量:21

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部